Carmot Therapeutics, Inc.
Registry sponsor category
Industry
- Other names
- Carmot Therapeutics, Inc.
- Company name
- Carmot Therapeutics, Inc.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (8)
- A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus
- A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
- A Study of CT-868 in Type 1 Diabetes Mellitus
- A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
- A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
- A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose
- A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
- Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus